BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Photofrin porfimer sodium regulatory update

FDA granted Orphan Drug designation for Pinnacle's Photofrin porfimer sodium to treat malignant pleural mesothelioma (MPM). The photodynamic therapy (PDT) with...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >